AI Podcast Interviews Articles and Reports

Months ago we featured Jessica Richman of uBiome on Emerj, which ended up leading us down a string of interesting startup emails related to "crowd sourcing." uBiome is aiming to crowd-source information about human health and our native bacteria (much as 23 and Me is aiming to do in genetics), Ivo Georgiev's project Proteo.me is designed around the gamification of combining existing proteins, and the list goes on.

In this episode, I interview Justin Brooke, Founder of IMScalable and renowned Media Buyer & Consultant. Justin talks about his strategies for setting up Facebook campaigns & implementation tips for Startups to effectively leverage Facebook ads to scale their customer base and revenue.

Dr. Anthony Wheeler got into management consulting because he wanted to help people, and to solve problems. Believing that academic work might allow for a more direct way to guide his work towards fixing issues and finding opportunities he wrapped up his PhD in business at the University of Oklahoma. Oddly enough, the position he found for himself is in the state that we might argue to be most in need for "help" on the entire east coast: Rhode Island. I sat down with the University of Rhode Island's energetic Dr. Wheeler to talk about how RI is aiming to overcome it's limitations, marshall it's resources, and remain an active home of business and innovation.

Have you ever wondered why some startups get loads of hype immediately after their launch and others don't? Is it down to an auspicious alignment of the planets or just sheer luck? The answer is neither; it's all down to virality. And according to leading expert in internet virality, Emerson Spartz, you have to create your own.

If you suspected that bioengineering is the new frontier of human endeavor, the experts agree. Genomics - with its proliferation of metaphors - scientists as pioneers and bioengineering as the home of innovation and rugged individualism - is the new Wild West. Consumer genomics, made possible by the plummeting costs of DNA testing and its growing popularity via the internet, is already a reality. Its current and future value in medical diagnostics, as well as a timetable within which it can become widely available as a healthcare tool for the general population, are the topic of much debate.

Tute Genomics is part of a grand shift towards the leveraging of genetic information towards better health and better treatments. One of the "holy grails" of this transition from one to the other is the advent of

Dr. Charles Sidman started off getting his Masters and PhD in Immunology and Harvard, and dove into research and professorship. It was thinking about the applications and possibilities of his research that brought him to the world of business and investments. "There's a part of grant writing where you have to mention significant - why your project matters in the world... that's what got involve with consulting activities, application and commercialization." This yearning to step outside the lab has resulted in hundreds of speeches, presentations and consulting jobs with companies and organizations around the world, eventually landing Charles in position as a Managing Partner of ECS Capital Partners, LLC.

Artificial intelligence has it’s advantages. Systematically, over decades of research and development, AI has come to dominate human intelligence in a number of specific and often limited tasks. Yet, AI - at least thus far - has still lagged human intelligence in certain types of rich pattern recognition. For example, AI programs are still comparatively inept with regards to picking up and handling different kinds of objects, and until recently, AI seemed to struggle vehemently in discerning a “cat” from a “dog” on a screen (see: Kaggle).